Tregs Attenuate Peripheral Oxidative Stress and Acute Phase Proteins in ALS
Open Access
- 7 May 2022
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 92 (2), 195-200
- https://doi.org/10.1002/ana.26375
Abstract
Oxidative stress (OS) induces inflammation, which in turn exacerbates OS and the expression of acute phase proteins (APPs). Regulatory T lymphocyte (Treg) therapy was assessed for suppression of OS and APP responses in longitudinal serum samples from subjects with amyotrophic lateral sclerosis (ALS) enrolled in a phase I clinical trial. The first round of Treg therapy suppressed levels of oxidized low-density lipoprotein (ox-LDL). During a 6-month washout period, ox-LDL levels increased. A second round of therapy again suppressed ox-LDL levels and then rose following the cessation of treatment. Serum levels of APPs, soluble CD14, lipopolysaccharide binding protein, and C-reactive protein, were stabilized during Treg administrations, but rose during the washout period and again after therapy was discontinued. Treg therapy potentially suppresses peripheral OS and the accompanying circulating pro-inflammatory induced APPs, both of which may serve as peripheral candidates for monitoring efficacies of immunomodulating therapies. ANN NEUROL 2022This publication has 21 references indexed in Scilit:
- Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis MonocytesJAMA Neurology, 2017
- ALS patients’ regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severityJCI Insight, 2017
- A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapyCytotherapy, 2016
- Expression and significance of plasma 3-NT and ox-LDL in patients with Alzheimer's diseaseEvolution, 2014
- LOX-1, OxLDL, and AtherosclerosisMediators of Inflammation, 2013
- Regulatory T‐lymphocytes mediate amyotrophic lateral sclerosis progression and survivalEMBO Molecular Medicine, 2012
- Oxidative stress in ALS: Key role in motor neuron injury and therapeutic targetFree Radical Biology & Medicine, 2010
- Low-grade systemic inflammation in patients with amyotrophic lateral sclerosisActa Neurologica Scandinavica, 2009
- Increased lipid peroxidation in sera of ALS patientsNeurology, 2004
- Natural history of amyotrophic lateral sclerosis in a database population Validation of a scoring system and a model for survival predictionBrain, 1995